Dark
Light
Today: June 3, 2024
January 31, 2024
1 min read

Startup Success: 7 Ingenious Funding Tactics You Must Explore

TLDR:

A lack of funding or investors is a major reason why startups fail, according to a survey of 500 founders. While venture capital is an option, it only funds a small percentage of startups. To overcome this funding gap, startups must explore alternative sources of funding. This article discusses seven creative ways to fund a startup beyond venture capital:

  • Bootstrapping: Founders rely on personal funds and revenue from the business to finance operations. For example, cybersecurity technology provider Cybervergent won a contract but didn’t have enough money to execute the project, so they asked for installment payments.
  • Crowdfunding: External parties contribute funds to the startup through platforms like Kickstarter and Indiegogo.
  • Grants: Non-refundable financing provided by governments, NGOs, and corporations, which do not accrue interest or require equity.
  • Angel Investors: Provide equity-based financing for startups, often investing at the early stage and leveraging their expertise and networks to help startups grow.
  • Revenue-based financing: Businesses give up a percentage of their revenues in exchange for invested money. Payment is determined by the startup’s revenues, providing flexibility.
  • Incubators: Nurtures early-stage startups by providing mentorship, tools, and networks. Incubators often provide early financing after startups achieve milestones.
  • Venture Debt: A loan to companies that have raised venture capital, providing non-dilutive capital and extending their runway.

These alternative funding sources can provide startups with the necessary capital to continue operations, grow, and overcome financial challenges.

Previous Story

Powering Innovation and Driving Regional Growth: Avanz Capital Egypt’s Bosta Investment

Next Story

Revolutionary Collaboration: SK Networks and Bow Capital Shape AI’s Future

Latest from Blog

Biophta Secures €65M to Fuel Growth and Innovation

TLDR: Biophta, a Paris-based preclinical biotech company, raised €6.5M in seed funding to accelerate trials for treating glaucoma and macular edema. Founded by experienced professionals, the company has developed an innovative technology
Go toTop